Search results
6 days ago · (Reuters) - Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing that targets a variant that was...
5 days ago · Novavax recently struck a licensing deal worth at least $1.2 billion with Sanofi (SASY.PA) for its COVID vaccine, bolstering a company that had lost most of its value since the pandemic. It was ...
May 14, 2024 · Novavax. People aged 12 years and older who got previous COVID-19 vaccine (s) People aged 12 years and older who got Pfizer-BioNTech or Moderna COVID-19 vaccines before September 12, 2023, or Novavax COVID-19 vaccine before October 3, 2023, should get 1 updated Pfizer-BioNTech, Moderna, or Novavax COVID-19 vaccine. Vaccine Overview.
May 10, 2024 · The Novavax COVID-19 vaccine is available for everyone 12 years and older. For those who have not received any previous COVID-19 vaccines, it is given as a two-dose primary series, eight weeks apart. If you have gotten a COVID-19 vaccine and your last dose was before September 2023, the Centers for Disease Control and Prevention (CDC ...
May 10, 2024 · Updated May 10, 2024, 10:48am EDT. Share to Facebook. Share to Twitter. Share to Linkedin. Topline. Shares for Novavax swelled by more than 130% Friday morning, after the biotech firm announced a...
- Ty Roush
May 10, 2024 · NEWS & MEDIA. Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines. May 10, 2024. Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwards.
May 10, 2024 · Novavax will receive $500 million in upfront payments as well as a further $700 million if all development, regulatory and launch milestones are met, according to a statement Bloomberg Terminal...
